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Surviving as a cancer survivor:
A case report of radiation-induced autonomic dysfunction
By Daphne Sy, MS3 & Mark Schauer, MD
Background:
While radiation and chemotherapy have achieved
high rates of cure for Hodgkin lymphoma, the
medical community is only now starting to characterize
the long-term effects of chemoradiation on young
survivors of cancers. New constellations of adverse
effects continue to develop even decades later, raising
questions:

Case Presentation:
A 41 year-old woman presents to the ED with exertional shortness of
breath, syncope, and chest pressure of increasing intensity for 2 days.
Her PMH includes DM type 2, morbid obesity, and Hodgkin lymphoma at
age 21, which was treated with ABVD and mantle radiation. Immediate
complications included pericardial fibrosis requiring window surgery, and
thyroid fibrosis requiring thyroidectomy. Over the past five years, she was
diagnosed with progressive pulmonary fibrosis of the R upper lobe. Last
year, a Type 2 AV block with episodes of syncope prompted AV pacemaker
placement..
During admission, providers witnessed several sudden drops in BP
(80s/40s) with reflex tachycardia (150s); these episodes would begin while the
patient was lying still and resolved spontaneously within 15 minutes.
Upon review of records from an outside facility, a cardiac workup in April
2016 included a TTE showing EF = 55-60%, amd heart catheterization
showed mild coronary artery disease and minimally elevated pulmonary artery
pressures. Despite these findings, she was diagnosed with heart failure
based on clinical symptoms and placed on daily furosemide.
During current admission, BNP and Troponin I x2 were negative. CXR
showed her heart size was at the upper borderline of normal; findings were
stable since previous visit. NM stress test and cardiac MRI were both
unremarkable.
A review of the long-term outcomes of Hodgkin lymphoma survivors
established that many patients continue to develop fibrotic sequelae from
chemoradiation, even two or more decades after their last treatment. Case
reports described other survivors with similar symptoms. Recently,
autonomic dysregulation independent of cardiac factors was shown in
both resting and exercising heart rates, increasing in direct correlation with
the number of years since therapy.

Figure 1. Data on survivorship derived from The German, Swiss and Austrian
Society of Paediatric Oncology and Haematology. From http://
www.forschenheiltkrebs.eu/

v Should long-term follow up of cancer survivors be
limited to five years with their oncologist?
v Is there enough need for “survivorship clinics”
devoted to the surveillance concerns of former
cancer patients?
v Should we train more PCPs who specialize in the
unique risks of cancer survivors?

Figure 3. A diagram of the
distribution of typical mantle
radiation, which was part of
standard of treatment for Hodgkin
lymphoma in 1990s This allows
us to anticipate organs of
possible involvement or future
concern. 3

Conclusions:
v Hodgkin lymphoma survivors have many unique
health concerns, such as increased rates of cancer,
progressive fibrosis of thoracic and neck organs,
and increased rates of cancers (e.g. esophageal).
v Anticipating these effects allows us to screen these
patients effectively and avoid repetitive expensive
workups.
v Current screening tests for autonomic dysfunction
are currently too expensive/high burden for wider
use; however, screening for cancers and fibrosis
may be beneficial.
v Effective treatment has not been described.
*Optimize intravascular volume
*No effective drugs for fibrosis
v There are many directions open to future research.
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